Concerns regarding the use of only phase 2 study to Justify palliative radiotherapy vs. Palliative chemo-radiotherapy in unresectable head and neck cancer

被引：0
|
作者：
Dave, Jay [1 ]
机构：
[1] Shree Doodhadhari Burfani Hosp, ENT HNS, Haridwar, India
来源：
RADIOTHERAPY AND ONCOLOGY | 2024年 / 200卷
关键词：
CHEMOTHERAPY; TRIAL;
D O I：
10.1016/j.radonc.2024.110526
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Short course radiotherapy for advanced head and neck cancer: a phase 2 study
    West, N.
    Zarroug, M.
    Patil, R.
    Kovarik, J.
    Kelly, C.
    Jackson, M.
    Iqbal, S.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S33 - S34
  • [22] A prospective randomized comparative study to evaluate the effect of palliative hypo-fractionated radiotherapy with concurrent chemotherapy versus hypo-fractionated radiotherapy alone in advanced and unresectable head and neck cancer with no metastasis
    Uttam, Aditya Kumar
    Yadav, Arun Kumar
    Jalota, Shreya
    Singh, Renu
    Malik, Shivani
    Arya, Ashok Kumar
    ECANCERMEDICALSCIENCE, 2023, 17
  • [23] Short course palliative radiotherapy of 20 Gy in 5 fractions for advanced and incurable head and neck cancer: AIIMS study
    Mohanti, BK
    Umapathy, H
    Bahadur, S
    Thakar, A
    Pathy, S
    RADIOTHERAPY AND ONCOLOGY, 2004, 71 (03) : 275 - 280
  • [24] Comparative Study of IMRT vs. Conventional Radiotherapy with Amifostine for Preservation of Parotid Function in Patients with Head and Neck Cancer
    Vyas, R.
    Patel, P. Nandvvani
    Patil, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S152 - S152
  • [25] The Effectiveness of PAlliative Split COurse RAdiotherapy (PASCORA) Regimen in Non-Metastatic Head and Neck Cancer Patients Who are Treated with Palliative Intent - A Retrospective Single Center Study
    Velu, U.
    Sharan, K.
    Singh, A.
    Salins, S.
    Reddy, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E312 - E312
  • [26] Comment on: "Short course palliative radiotherapy of 20 Gy in 5 fractions for advanced and incurable head and neck cancer: AIIMS study" Reply
    Mohanti, BK
    RADIOTHERAPY AND ONCOLOGY, 2005, 74 (01) : 75 - 76
  • [27] The impact of palliative radiotherapy on health-related quality of life in patients with head and neck cancer - Results of a multicenter prospective cohort study
    Weiss, Marie-Luise
    Domschikowski, Justus
    Krug, David
    Sonnhoff, Mathias
    Nitsche, Mirko
    Hoffmann, Wolfgang
    Becker-Schiebe, Martina
    Bock, Felix
    Hoffmann, Markus
    Schmalz, Claudia
    Dunst, Juergen
    Fabian, Alexander
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2023, 41
  • [28] Outcome of Hypofractionated Palliative Radiotherapy Regimens for Patients With Advanced Head and Neck Cancer in Tikur Anbessa Hospital, Ethiopia: A Prospective Cohort Study
    Zingeta, Girum Tessema
    Worku, Yohannes Tesfaye
    Awol, Munir
    Woldetsadik, Edom Seife
    Assefa, Mathewos
    Chama, Tsion Zebdios
    Feyisa, Jilcha Diribi
    Bedada, Hawi Furgassa
    Adem, Mohammed Ibrahim
    Mengesha, Tariku
    Wong, Rebecca
    JCO GLOBAL ONCOLOGY, 2024, 10
  • [29] Palliative radiotherapy and chemotherapy instead of surgery in symptomatic rectal cancer with synchronous unresectable metastases: long-term results of a phase II study
    Tyc-Szczepaniak, Dobromira
    Wyrwicz, Lucjan
    Wisniowska, Katarzyna
    Michalski, Wojciech
    Pietrzak, Lucyna
    Bujko, Krzysztof
    ACTA ONCOLOGICA, 2016, 55 (11) : 1369 - 1370
  • [30] THE ROLE OF COX-2 INHIBITOR (CELECOXIB) IN COMBINATION WITH CHEMO-RADIOTHERAPY IN HEAD AND NECK CARCINOMA TO REDUCE ACUTE TOXICITIES, PHASE III, RANDOMIZED CLINICAL TRIAL
    Aghili, M.
    Mojahed, M.
    Kazemian, A.
    Izadi, S.
    Farhan, F.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S151 - S151
12345